GH1 and acromegaly: Medical therapy of acromegaly is indicated in patients who failed to achieve the current remission criteria, that is, (i) a GH nadir below 1 μg/L during a 75 g oral glucose load, (ii) a normal age- and sex-adjusted IGF-1 concentration either after surgery or following radiotherapy.